Literature DB >> 30601183

Minimally invasive approaches to the inguinal nodes in cN0 patients.

Reza Nabavizadeh1, Viraj Master.   

Abstract

PURPOSE OF REVIEW: In penile cancer, lymphadenectomy can have staging and possibly therapeutic values. However, many physicians and patients are reluctant when it comes to inguinal lymph node dissection (ILND) due to high rate of surgical morbidities. In recent years, minimally invasive surgical approaches have shown success in reducing perioperative morbidities. RECENT
FINDINGS: Newer surgical modalities, including videoscopic inguinal lymphadenectomy and robotic-assisted inguinal lymphadenectomy, have been explored to reduce the morbidities of ILND while not compromising oncologic outcomes. Data on this topic is limited but available data suggest that these minimally invasive techniques are safe and associated with less perioperative morbidities. There is no study to directly compare the oncological outcome between these different techniques. However, number of dissected lymph nodes is used a surrogate for oncologic outcomes. Different treatment approaches including open, laparoscopic, and robotic seem to be similar and effective in terms of nodal yield.
SUMMARY: Laparoscopic and robotic approaches are successful in dissecting inguinal lymph nodes and are associated with lower rate of major perioperative complications. Individual patient's characteristics as well as surgeon's experience should be considered when trying to decide the optimum surgical modality for ILND.

Entities:  

Mesh:

Year:  2019        PMID: 30601183     DOI: 10.1097/MOU.0000000000000588

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  1 in total

Review 1.  Robot-assisted endoscopic inguinal lymphadenectomy: A review of current outcomes.

Authors:  Gilberto José Rodrigues; Giuliano Betoni Guglielmetti; Marcelo Orvieto; Kulthe Ramesh Seetharam Bhat; Vipul R Patel; Rafael Ferreira Coelho
Journal:  Asian J Urol       Date:  2020-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.